EPIRUS
Biopharmaceuticals, Inc. is no longer publicly traded. It was delisted
from NASDAQ in 2018 and its assets were sold to a private company.
Therefore, there is no available information on its current status or
any exchange-traded products related to it.
EPIRUS
Biopharmaceuticals, Inc. is no longer publicly traded. It was delisted
from NASDAQ in 2018 and its assets were sold to a private company.
Therefore, there is no available information on its current status or
any exchange-traded products related to it.